{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T19:45:12Z","timestamp":1772135112731,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T00:00:00Z","timestamp":1639612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T00:00:00Z","timestamp":1639612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The global disruption caused by the 2020 coronavirus pandemic stressed the supply chain of many products, including pharmaceuticals. Multiple drug repurposing studies for COVID-19 are now underway. If a winning therapeutic emerges, it is unlikely that the existing inventory of the medicine, or even the chemical raw materials needed to synthesize it, will be available in the quantities required. Here, we utilize retrosynthetic software to arrive at alternate chemical supply chains for the antiviral drug umifenovir, as well as eleven other antiviral and anti-inflammatory drugs. We have experimentally validated four routes to umifenovir and one route to bromhexine. In one route to umifenovir the software invokes conversion of six C\u2013H bonds into C\u2013C bonds or functional groups. The strategy we apply of excluding known starting materials from search results can be used to identify distinct starting materials, for instance to relieve stress on existing supply chains.<\/jats:p>","DOI":"10.1038\/s41467-021-27547-3","type":"journal-article","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T06:07:13Z","timestamp":1639634833000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Reinforcing the supply chain of umifenovir and other antiviral drugs with retrosynthetic software"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1756-6636","authenticated-orcid":false,"given":"Yingfu","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zirong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8225-6514","authenticated-orcid":false,"given":"Babak","family":"Mahjour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunjae","family":"Shim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"McGrath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7234-1136","authenticated-orcid":false,"given":"Yuning","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Brugger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Turnbull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Trice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shashi","family":"Jasty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5407-0643","authenticated-orcid":false,"given":"Tim","family":"Cernak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,16]]},"reference":[{"key":"27547_CR1","unstructured":"Temporary Policy for Preparation of Certain Alcohol-Based Hand Sanitizer Products During the Public Health Emergency (COVID-19) Guidance for Industry. https:\/\/www.fda.gov\/media\/136289\/download (Food and Drug Administration, 2020)."},{"key":"27547_CR2","doi-asserted-by":"publisher","first-page":"e0234232","DOI":"10.1371\/journal.pone.0234232","volume":"15","author":"L Garbe","year":"2020","unstructured":"Garbe, L., Rau, R. & Toppe, T. Influence of perceived threat of Covid-19 and HEXACO personality traits on toilet paper stockpiling. PLoS ONE 15, e0234232 (2020).","journal-title":"PLoS ONE"},{"key":"27547_CR3","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/d41586-020-01367-9","volume":"581","author":"H Ledford","year":"2020","unstructured":"Ledford, H. Dozens of coronavirus drugs are in development\u2014what happens next? Nature 581, 247\u2013248 (2020).","journal-title":"Nature"},{"key":"27547_CR4","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1126\/science.abb9332","volume":"368","author":"RK Guy","year":"2020","unstructured":"Guy, R. K., DiPaola, R. S., Romanelli, F. & Dutch, R. E. Rapid repurposing of drugs for COVID-19. Science 368, 829\u2013830 (2020).","journal-title":"Science"},{"key":"27547_CR5","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.cmi.2020.05.019","volume":"26","author":"PC Fragkou","year":"2020","unstructured":"Fragkou, P. C. et al. Review of trials currently testing treatment and prevention of COVID-19. Clin. Microbiol. Infect. 26, 988\u2013998 (2020).","journal-title":"Clin. Microbiol. Infect."},{"key":"27547_CR6","unstructured":"COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). Available at https:\/\/coronavirus.jhu.edu\/map.html. Accessed Dec 9, 2020."},{"key":"27547_CR7","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1021\/acscentsci.0c00637","volume":"6","author":"MA Hardy","year":"2020","unstructured":"Hardy, M. A. et al. Treating a global health crisis with a dose of synthetic chemistry. ACS Cent. Sci. 6, 1017\u20131030 (2020).","journal-title":"ACS Cent. Sci."},{"key":"27547_CR8","unstructured":"\u201cWorking to Supply Remdesivir for COVID-19.\u201d (I. Gilead Sciences, 2020). Available at https:\/\/www.gilead.com\/purpose\/advancing-global-health\/covid-19\/working-to-supply-remdesivir-for-covid-19."},{"key":"27547_CR9","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/jmv.26256","volume":"93","author":"D Huang","year":"2020","unstructured":"Huang, D. et al. Efficacy and safety of umifenovir for coronavirus disease 2019 (COVID\u201019): a systematic review and meta\u2010analysis. J. Med. Virol. 93, 481\u2013490 (2020).","journal-title":"J. Med. Virol"},{"key":"27547_CR10","doi-asserted-by":"publisher","first-page":"6736","DOI":"10.1039\/D0SC01799J","volume":"11","author":"S Szymkuc","year":"2020","unstructured":"Szymkuc, S. et al. Computer-generated \u201csynthetic contingency\u201d plans at times of logistics and supply problems: scenarios for hydroxychloroquine and remdesivir. Chem. Sci. 11, 6736\u20136744 (2020).","journal-title":"Chem. Sci."},{"key":"27547_CR11","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1126\/science.166.3902.178","volume":"166","author":"EJ Corey","year":"1969","unstructured":"Corey, E. J. & Wipke, W. T. Computer-assisted design of complex organic syntheses. Science 166, 178\u2013192 (1969).","journal-title":"Science"},{"key":"27547_CR12","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.1002\/anie.201506101","volume":"55","author":"S Szymkuc","year":"2016","unstructured":"Szymkuc, S. et al. Computer-assisted synthetic planning: the end of the beginning. Angew. Chem. Int. Ed. Engl. 55, 5904\u20135937 (2016).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"27547_CR13","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/nature25978","volume":"555","author":"MHS Segler","year":"2018","unstructured":"Segler, M. H. S., Preuss, M. & Waller, M. P. Planning chemical syntheses with deep neural networks and symbolic AI. Nature 555, 604\u2013610 (2018).","journal-title":"Nature"},{"key":"27547_CR14","doi-asserted-by":"publisher","first-page":"eaax1566","DOI":"10.1126\/science.aax1566","volume":"365","author":"CW Coley","year":"2019","unstructured":"Coley, C. W. et al. A robotic platform for flow synthesis of organic compounds informed by AI planning. Science 365, eaax1566 (2019).","journal-title":"Science"},{"key":"27547_CR15","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/anie.201912083","volume":"59","author":"T Badowski","year":"2020","unstructured":"Badowski, T., Gajewska, E. P., Molga, K. & Grzybowski, B. A. Synergy between expert and machine-learning approaches allows for improved retrosynthetic planning. Angew. Chem. Int. Ed. Engl. 59, 725\u2013730 (2020).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"27547_CR16","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.chempr.2018.02.002","volume":"4","author":"T Klucznik","year":"2018","unstructured":"Klucznik, T. et al. Efficient syntheses of diverse, medicinally relevant targets planned by computer and executed in the laboratory. Chemistry 4, 522\u2013532 (2018).","journal-title":"Chemistry"},{"key":"27547_CR17","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.chempr.2018.12.004","volume":"5","author":"K Molga","year":"2019","unstructured":"Molga, K., Dittwald, P. & Grzybowski, B. A. Navigating around patented routes by preserving specific motifs along computer-planned retrosynthetic pathways. Chemistry 5, 460\u2013473 (2019).","journal-title":"Chemistry"},{"key":"27547_CR18","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1021\/acs.accounts.8b00087","volume":"51","author":"CW Coley","year":"2018","unstructured":"Coley, C. W., Green, W. H. & Jensen, K. F. Machine learning in computer-aided synthesis planning. Acc. Chem. Res. 51, 1281\u20131289 (2018).","journal-title":"Acc. Chem. Res."},{"key":"27547_CR19","doi-asserted-by":"publisher","first-page":"12152","DOI":"10.1039\/C9CC05122H","volume":"55","author":"AA Lee","year":"2019","unstructured":"Lee, A. A. et al. Molecular transformer unifies reaction prediction\u201a and retrosynthesis across pharma chemical space. Chem. Commun. 55, 12152\u201312155 (2019).","journal-title":"Chem. Commun."},{"key":"27547_CR20","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41586-020-2855-y","volume":"588","author":"B Mikulak-Klucznik","year":"2020","unstructured":"Mikulak-Klucznik, B. et al. Computational planning of the synthesis of complex natural products. Nature 588, 83\u201388 (2020).","journal-title":"Nature"},{"key":"27547_CR21","unstructured":"Available at http:\/\/covidroutes.cernaklab.com."},{"key":"27547_CR22","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.cmi.2020.04.026","volume":"26","author":"N Lian","year":"2020","unstructured":"Lian, N. et al. Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study. Clin. Microbiol. Infect. 26, 917\u2013921 (2020).","journal-title":"Clin. Microbiol. Infect."},{"key":"27547_CR23","doi-asserted-by":"publisher","first-page":"7230","DOI":"10.1002\/anie.200802482","volume":"47","author":"S W\u00fcrtz","year":"2008","unstructured":"W\u00fcrtz, S., Rakshit, S., Neumann, J. J., Dr\u00f6ge, T. & Glorius, F. Palladium-catalyzed oxidative cyclization of N-aryl enamines: from anilines to indoles. Angew. Chem. Int. Ed. Engl. 47, 7230\u20137233 (2008).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"27547_CR24","doi-asserted-by":"publisher","first-page":"3362","DOI":"10.1002\/anie.201006368","volume":"50","author":"T Newhouse","year":"2011","unstructured":"Newhouse, T. & Baran, P. S. If C\u2013H bonds could talk: selective C\u2013H bond oxidation. Angew. Chem. Int. Ed. Engl. 50, 3362\u20133374 (2011).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"27547_CR25","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1039\/C5CS00628G","volume":"45","author":"T Cernak","year":"2016","unstructured":"Cernak, T., Dykstra, K. D., Tyagarajan, S., Vachal, P. & Krska, S. W. The medicinal chemist\u2019s toolbox for late stage functionalization of drug-like molecules. Chem. Soc. Rev. 45, 546\u2013576 (2016).","journal-title":"Chem. Soc. Rev."},{"key":"27547_CR26","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1021\/acscentsci.7b00329","volume":"3","author":"HML Davies","year":"2017","unstructured":"Davies, H. M. L. & Morton, D. Collective approach to advancing C\u2013H functionalization. ACS Cent. Sci. 3, 936\u2013943 (2017).","journal-title":"ACS Cent. Sci."},{"key":"27547_CR27","unstructured":"E. J. Corey. The Logic of Chemical Synthesis (Nobel Foundation, [Nobelstiftelsen], 1991)."},{"key":"27547_CR28","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.3987\/R-1987-06-1471","volume":"26","author":"S Nakatsuka","year":"1987","unstructured":"Nakatsuka, S., Asano, O., Ueda, K. & Goto, T. Introduction of a hydroxy group onto 5- and 6-position of indole nucleus by Friedel-Crafts acylation and subsequent Baeyer-Villiger oxidation. Heterocycles 26, 1471\u20131474 (1987).","journal-title":"Heterocycles"},{"key":"27547_CR29","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1070\/RCR4791","volume":"87","author":"KV Balakin","year":"2018","unstructured":"Balakin, K. V. et al. Arbidol: a quarter-century after. Past, present and future of the original Russian antiviral. Russ. Chem. Rev. 87, 509\u2013552 (2018).","journal-title":"Russ. Chem. Rev."},{"key":"27547_CR30","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1016\/j.bmcl.2017.06.074","volume":"27","author":"ZVF Wright","year":"2017","unstructured":"Wright, Z. V. F., Wu, N. C., Kadam, R. U., Wilson, I. A. & Wolan, D. W. Structure-based optimization and synthesis of antiviral drug Arbidol analogues with significantly improved affinity to influenza hemagglutinin. Bioorg. Med. Chem. 27, 3744\u20133748 (2017).","journal-title":"Bioorg. Med. Chem."},{"key":"27547_CR31","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1021\/ol300853z","volume":"14","author":"K Moriyama","year":"2012","unstructured":"Moriyama, K., Takemura, M. & Togo, H. Direct and selective benzylic oxidation of alkylarenes via C-H abstraction using alkali metal bromides. Org. Lett. 14, 2414\u20132417 (2012).","journal-title":"Org. Lett."},{"key":"27547_CR32","doi-asserted-by":"publisher","first-page":"10526","DOI":"10.1021\/jacs.0c03592","volume":"142","author":"Y Kanda","year":"2020","unstructured":"Kanda, Y. et al. Two-phase synthesis of taxol. J. Am. Chem. Soc. 142, 10526\u201310533 (2020).","journal-title":"J. Am. Chem. Soc."},{"key":"27547_CR33","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1021\/ja00506a013","volume":"101","author":"M Krumpolc","year":"1979","unstructured":"Krumpolc, M. & Ro\u010dek, J. Synthesis of stable chromium(V) complexes of tertiary hydroxy acids. J. Am. Chem. Soc. 101, 3206\u20133209 (1979).","journal-title":"J. Am. Chem. Soc."},{"key":"27547_CR34","doi-asserted-by":"publisher","first-page":"4188","DOI":"10.1002\/ejoc.201700548","volume":"2017","author":"R Ueno","year":"2017","unstructured":"Ueno, R., Ikeda, Y. & Shirakawa, E. tert-Butoxy-radical-promoted \u03b1-arylation of alkylamines with aryl halides. Eur. J. Org. Chem. 2017, 4188\u20134193 (2017).","journal-title":"Eur. J. Org. Chem."}],"updated-by":[{"DOI":"10.1038\/s41467-022-29041-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000}}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27547-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27547-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27547-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T14:36:42Z","timestamp":1669991802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27547-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,16]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["27547"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-27547-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-820369\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,16]]},"assertion":[{"value":"4 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41467-022-29041-w","URL":"https:\/\/doi.org\/10.1038\/s41467-022-29041-w","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Cernak Lab has received research funding or in-kind donations from Merck, Relay Therapeutics, Janssen Therapeutics, SPT Labtech, and MSD. T.C. holds equity in Scorpion Therapeutics, and is a co-Founder and equity holder of Entos, Inc.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7327"}}